98 Albany Street
Crows Nest, Sydney,
NSW 2065, Australia
tel: 02 9438 2900
fax: 02 9438 2400
Professor Leigh Delbridge
BSc(Med) MBBS MD FRACS FACS FCSSL(Hon)
the most experienced parathyroid and thyroid surgeon in Australia
Telehealth consultations by phone, FaceTime or Skype are available for all patients.
Face to face consultations in the office with precautions in place to avoid any issues with COVID- 19. Face masks are no longer routinely required.
High rate of cancer in Hashimoto's thyroiditis
Hashimoto's thyroiditis is usually treated conservatively by monitoring and administration of thyroxine when hypothyroidism occurs. Surgery may be performed when nodules develop or when the inflammation causes pressure symptoms, but this is uncommon as it has been considered that thyroidectomy in the presence of Hashimoto's thyroiditis is more dangerous with a higher complication rate due to the inflammation and scarring. In a recent paper from Dr Quan Duh's unit in San Francisco (see link to abstract), a series of 474 patients undergoing surgery for Hashimoto's thyroiditis were studied. Most of these patients required surgery for what were thought to be benign nodules or for pressure symptoms with only 133 having a pre-operative diagnosis of cancer. Despite the technical difficulties of surgery, there was a very low complication rate with bleeding in only 0.8% (4 patients) and temporary damage to the recurrent laryngeal nerve in only 0.4% (2 patients). No permanent complications occurred in the series. Surprisingly the final pathology reported thyroid cancer in the more than half of the patients (53%). The authors conclude that cancer is common in patients who have a thyroidectomy for Hashimoto's thyroiditis even when not suspected pre-operatively. Concerns about surgery being more complicated and therefore avoided are not supported by the published outcomes when performed in a high volume centre.